In a paper just published in Science, Prof. Chris Snyder and 15 co-authors make the argument that investing in greater capacity for vaccine developement now will pay enormous dividends in both lives saved and economic harm averted.
Market design to accelerate COVID-19 vaccine supply
Prof. Chris Snyder's research is published in Science.
Image
